| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |